Trial Profile
A Step therapy by a premixed insulin therapies in poor control with type 2 diabetes
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2012
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin glargine (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Sep 2012 New trial record